Antecedent hypercortisolemia is not primarily responsible for generating hypoglycemia-associated autonomic failure

Philip A. Goldberg, Ram Weiss, Rory J. McCrimmon, Ellen V. Hintz, James D. Dziura, Robert S. Sherwin (Lead / Corresponding author)

    Research output: Contribution to journalArticle

    22 Citations (Scopus)

    Abstract

    Hypoglycemia-associated autonomic failure (HAAF) occurs commonly in patients with longstanding diabetes, placing affected patients at increased risk for severe hypoglycemia. Previous studies have suggested that hypoglycemia-induced hypercortisolemia may be responsible for blunting subsequent sympathoadrenal responses to hypoglycemia; however, this view remains highly controversial. In this work, we sought to better define the role of antecedent hypercortisolemia in generating HAAF, using two complimentary experimental models in nondiabetic human subjects: 1) antecedent hydrocortisone infusions (simulating physiologic cortisol responses to hypoglycemia) and 2) antecedent hypoglycemia, with and without concurrent blockade of endogenous cortisol production using oral metyrapone. Our results showed no effect of antecedent hypercortisolemia on epinephrine responses to subsequent hypoglycemia (area under the curve/time 280 +/- 53 vs. 337 +/- 57 pg/ml, P = 0.16). Of particular importance, selective blockade of endogenous cortisol production during antecedent hypoglycemia had no effect on subsequent counterregulatory responses to hypoglycemia. Compared with epinephrine responses following antecedent euglycemia (area under the curve/time 312 +/- 38 pg/ml), epinephrine responses were comparably blunted following antecedent hypoglycemia, regardless of whether concurrent metyrapone blockade was employed (198 +/- 28 vs. 192 +/- 28 pg/ml, P = NS). Similar results were obtained for glucagon and ACTH levels. Considered together, these observations provide strong evidence that hypoglycemia-induced hypercortisolemia is not primarily responsible for the generation of HAAF.
    Original languageEnglish
    Pages (from-to)1121-1126
    Number of pages6
    JournalDiabetes
    Volume55
    Issue number4
    DOIs
    Publication statusPublished - Apr 2006

    Fingerprint

    Hypoglycemia
    Hydrocortisone
    Epinephrine
    Metyrapone
    Area Under Curve
    Glucagon
    Adrenocorticotropic Hormone
    Theoretical Models

    Cite this

    Goldberg, Philip A. ; Weiss, Ram ; McCrimmon, Rory J. ; Hintz, Ellen V. ; Dziura, James D. ; Sherwin, Robert S. / Antecedent hypercortisolemia is not primarily responsible for generating hypoglycemia-associated autonomic failure. In: Diabetes. 2006 ; Vol. 55, No. 4. pp. 1121-1126.
    @article{7a862f4b620a4c9d9dace0359d3e3d3b,
    title = "Antecedent hypercortisolemia is not primarily responsible for generating hypoglycemia-associated autonomic failure",
    abstract = "Hypoglycemia-associated autonomic failure (HAAF) occurs commonly in patients with longstanding diabetes, placing affected patients at increased risk for severe hypoglycemia. Previous studies have suggested that hypoglycemia-induced hypercortisolemia may be responsible for blunting subsequent sympathoadrenal responses to hypoglycemia; however, this view remains highly controversial. In this work, we sought to better define the role of antecedent hypercortisolemia in generating HAAF, using two complimentary experimental models in nondiabetic human subjects: 1) antecedent hydrocortisone infusions (simulating physiologic cortisol responses to hypoglycemia) and 2) antecedent hypoglycemia, with and without concurrent blockade of endogenous cortisol production using oral metyrapone. Our results showed no effect of antecedent hypercortisolemia on epinephrine responses to subsequent hypoglycemia (area under the curve/time 280 +/- 53 vs. 337 +/- 57 pg/ml, P = 0.16). Of particular importance, selective blockade of endogenous cortisol production during antecedent hypoglycemia had no effect on subsequent counterregulatory responses to hypoglycemia. Compared with epinephrine responses following antecedent euglycemia (area under the curve/time 312 +/- 38 pg/ml), epinephrine responses were comparably blunted following antecedent hypoglycemia, regardless of whether concurrent metyrapone blockade was employed (198 +/- 28 vs. 192 +/- 28 pg/ml, P = NS). Similar results were obtained for glucagon and ACTH levels. Considered together, these observations provide strong evidence that hypoglycemia-induced hypercortisolemia is not primarily responsible for the generation of HAAF.",
    author = "Goldberg, {Philip A.} and Ram Weiss and McCrimmon, {Rory J.} and Hintz, {Ellen V.} and Dziura, {James D.} and Sherwin, {Robert S.}",
    note = "M1 - 4 Goldberg, Philip A Weiss, Ram McCrimmon, Rory J Hintz, Ellen V Dziura, James D Sherwin, Robert S eng DK20495/DK/NIDDK NIH HHS/ M01 RR-00125/RR/NCRR NIH HHS/ Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't 2006/03/29 09:00 Diabetes. 2006 Apr;55(4):1121-6.",
    year = "2006",
    month = "4",
    doi = "10.2337/diabetes.55.04.06.db05-1169",
    language = "English",
    volume = "55",
    pages = "1121--1126",
    journal = "Diabetes",
    issn = "0012-1797",
    publisher = "American Diabetes Association",
    number = "4",

    }

    Antecedent hypercortisolemia is not primarily responsible for generating hypoglycemia-associated autonomic failure. / Goldberg, Philip A.; Weiss, Ram; McCrimmon, Rory J.; Hintz, Ellen V.; Dziura, James D.; Sherwin, Robert S. (Lead / Corresponding author).

    In: Diabetes, Vol. 55, No. 4, 04.2006, p. 1121-1126.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Antecedent hypercortisolemia is not primarily responsible for generating hypoglycemia-associated autonomic failure

    AU - Goldberg, Philip A.

    AU - Weiss, Ram

    AU - McCrimmon, Rory J.

    AU - Hintz, Ellen V.

    AU - Dziura, James D.

    AU - Sherwin, Robert S.

    N1 - M1 - 4 Goldberg, Philip A Weiss, Ram McCrimmon, Rory J Hintz, Ellen V Dziura, James D Sherwin, Robert S eng DK20495/DK/NIDDK NIH HHS/ M01 RR-00125/RR/NCRR NIH HHS/ Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't 2006/03/29 09:00 Diabetes. 2006 Apr;55(4):1121-6.

    PY - 2006/4

    Y1 - 2006/4

    N2 - Hypoglycemia-associated autonomic failure (HAAF) occurs commonly in patients with longstanding diabetes, placing affected patients at increased risk for severe hypoglycemia. Previous studies have suggested that hypoglycemia-induced hypercortisolemia may be responsible for blunting subsequent sympathoadrenal responses to hypoglycemia; however, this view remains highly controversial. In this work, we sought to better define the role of antecedent hypercortisolemia in generating HAAF, using two complimentary experimental models in nondiabetic human subjects: 1) antecedent hydrocortisone infusions (simulating physiologic cortisol responses to hypoglycemia) and 2) antecedent hypoglycemia, with and without concurrent blockade of endogenous cortisol production using oral metyrapone. Our results showed no effect of antecedent hypercortisolemia on epinephrine responses to subsequent hypoglycemia (area under the curve/time 280 +/- 53 vs. 337 +/- 57 pg/ml, P = 0.16). Of particular importance, selective blockade of endogenous cortisol production during antecedent hypoglycemia had no effect on subsequent counterregulatory responses to hypoglycemia. Compared with epinephrine responses following antecedent euglycemia (area under the curve/time 312 +/- 38 pg/ml), epinephrine responses were comparably blunted following antecedent hypoglycemia, regardless of whether concurrent metyrapone blockade was employed (198 +/- 28 vs. 192 +/- 28 pg/ml, P = NS). Similar results were obtained for glucagon and ACTH levels. Considered together, these observations provide strong evidence that hypoglycemia-induced hypercortisolemia is not primarily responsible for the generation of HAAF.

    AB - Hypoglycemia-associated autonomic failure (HAAF) occurs commonly in patients with longstanding diabetes, placing affected patients at increased risk for severe hypoglycemia. Previous studies have suggested that hypoglycemia-induced hypercortisolemia may be responsible for blunting subsequent sympathoadrenal responses to hypoglycemia; however, this view remains highly controversial. In this work, we sought to better define the role of antecedent hypercortisolemia in generating HAAF, using two complimentary experimental models in nondiabetic human subjects: 1) antecedent hydrocortisone infusions (simulating physiologic cortisol responses to hypoglycemia) and 2) antecedent hypoglycemia, with and without concurrent blockade of endogenous cortisol production using oral metyrapone. Our results showed no effect of antecedent hypercortisolemia on epinephrine responses to subsequent hypoglycemia (area under the curve/time 280 +/- 53 vs. 337 +/- 57 pg/ml, P = 0.16). Of particular importance, selective blockade of endogenous cortisol production during antecedent hypoglycemia had no effect on subsequent counterregulatory responses to hypoglycemia. Compared with epinephrine responses following antecedent euglycemia (area under the curve/time 312 +/- 38 pg/ml), epinephrine responses were comparably blunted following antecedent hypoglycemia, regardless of whether concurrent metyrapone blockade was employed (198 +/- 28 vs. 192 +/- 28 pg/ml, P = NS). Similar results were obtained for glucagon and ACTH levels. Considered together, these observations provide strong evidence that hypoglycemia-induced hypercortisolemia is not primarily responsible for the generation of HAAF.

    U2 - 10.2337/diabetes.55.04.06.db05-1169

    DO - 10.2337/diabetes.55.04.06.db05-1169

    M3 - Article

    VL - 55

    SP - 1121

    EP - 1126

    JO - Diabetes

    JF - Diabetes

    SN - 0012-1797

    IS - 4

    ER -